A week into his tenure as head of the FDA’s Center for Drug Evaluation and Research, experts agree that Rick Pazdur is the “ideal fit” to stabilize the agency. And, according to one ex-FDA official, ...
Health Secretary Robert Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.
Clinical Trials Arena on MSN
FDA’s revolving door reveals Pazdur as new CDER head
"FDA’s revolving door reveals Pazdur as new CDER head" was originally created and published by Clinical Trials Arena, a ...
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback